Posted inBiotechnology Biofortified millet boosts toddler nutrition without supplement side effects August 5, 2026 Iron deficiency affects about one in four people worldwide, with young children among those at greatest risk. In early life,…
Posted inGenetics Electrical Stimulation’s Effects on Neurons, Gene Expression Mapped in Living Human Brain Tissue August 5, 2026 Credit: da-kuk / iStock / Getty Images Plus Neurons from living human brain tissue have helped researchers trace how electrical…
Posted inBiotechnology IL-1 Signaling Strengthens Mucosal Defense Against Systemic Candida albicans Infection August 5, 2026 A new study published in Nature Microbiology identifies signalling pathways from the interleukin-1 family as key drivers of mucosal defence…
Posted inBiotechnology How BRI1 Receptors Recognize Diverse Brassinosteroid Hormones August 5, 2026 Brassinosteroids are among the most influential hormones in plant biology, yet the molecular logic that allows plants to recognize such…
Posted inBiotechnology Hippocampal Wiring Study Finds Graded Mossy Fiber Inputs and Targeted Inhibition August 5, 2026 The hippocampus is often portrayed as a single memory machine, but a new connectomics study suggests that one of its…
Posted inBiotechnology Palmitate Drives Liver Metastasis by Suppressing Neutrophils’ Antitumour Activity August 5, 2026 Liver metastases are among the most difficult complications of advanced cancer. Unlike many other organs, the liver is continuously exposed…
Posted inBiotechnology Single-nucleus analysis reveals human fat-cell subsets with distinct metabolic profiles August 5, 2026 White fat is often portrayed as a passive storage depot, a biological warehouse where excess energy is packed away for…
Posted inBiotechnology Ultrasound-Guided Nasojejunal Tube Placement Reduces Malposition and Radiation in Newborns August 5, 2026 A bedside ultrasound technique is emerging as a potential alternative to repeated X-ray checks for placing nasojejunal feeding tubes in…
Posted inBiotechnology Sanofi suspends chronic lung disease phase 2 study, tied to ‘strategic business reasons’ August 5, 2026 Sanofi halted a phase 2 trial testing a monoclonal antibody, SAR445399, in non-cystic fibrosis bronchiectasis, Fierce has learned.
Posted inGenetics Enzene Targets Local Biomanufacturing with New Solutions August 5, 2026 Enzene's fully-connected continuous biomanufacturing platform. [Enzene] CDMO Enzene launched NeX™, which it labels “an end-to-end partnership model that enables governments,…